-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the European General Court of Justice annulled the European Commission's decision
on the classification of titanium dioxide carcinogenicity.
In February 2020, according to the 14th amendment to the EU CLP Regulation (EC) 1272/2008, the European Commission classified titanium dioxide as inhalation carcinogenicity category 2, i.
e.
titanium dioxide powder with an aerodynamic diameter of less than or equal to 10 μm particles is considered potentially carcinogenic by inhalation (H351).
(For details, please refer to previous articles: titanium dioxide, coatings, cosmetics and other enterprises pay attention!) Titanium dioxide is classified as a suspected carcinogen by the European Union)
Producers, importers, distributors and downstream users of titanium dioxide have strongly opposed this classification and jointly filed a lawsuit
with the European General Court.
Regarding the controversial point on the basis of the classification of titanium dioxide, we also mentioned in an article last year: nearly one-third of employees were physically detected with lung nodules, which are related to formaldehyde removal potions?
Recently, this controversy, which has lasted for several years, finally ushered in the dawn, the European Court of Justice held that based on the current evidence, the EU Risk Assessment Committee RAC made a clear error in assessing the acceptability and reliability of scientific research on inhalation carcinogenicity, and its assessment conclusion violated the classification and labeling standards of carcinogens established by the EU CLP regulation, because the hazard classification should be based on the intrinsic intrinsic properties of the substance, not the characteristics affected by several factors, if carcinogenicity is only related to certain inhalable titanium dioxide particles and lung load.
It can only be a specific complementary condition, not an intrinsic property
of titanium dioxide.
The decision therefore also requires the European Commission to fill in the correction
of any legal measure arising from the invalidity of the change in classification within one year.
The current ruling opinion is undoubtedly a major positive news for the titanium dioxide industry, although the removal of the unified classification will need to wait for further action
by the European Commission.
Ruio Technology recommends that enterprises continue to pay attention to the progress of the classification incident and adjust product labels and classifications
in a timely manner.